Tolvaptan improves the diurnal blood pressure profile in patients with hypertension and autosomal-dominant polycystic kidney disease
- DOI
- 10.1093/ajh/hpag035
- Published
- 2026-04-28
- Container
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ajh/hpag035,
title = {Tolvaptan improves the diurnal blood pressure profile in patients with hypertension and autosomal-dominant polycystic kidney disease},
author = {Masaaki Hanaoka and Hiromichi Wakui and Daisuke Kanai and Sho Kinguchi and Kengo Azushima and Toshimasa Ohnishi and Kouichi Tamura},
year = {2026},
journal = {American Journal of Hypertension},
doi = {10.1093/ajh/hpag035},
url = {https://doi.org/10.1093/ajh/hpag035}
}RIS
TY - JOUR TI - Tolvaptan improves the diurnal blood pressure profile in patients with hypertension and autosomal-dominant polycystic kidney disease AU - Masaaki Hanaoka AU - Hiromichi Wakui AU - Daisuke Kanai AU - Sho Kinguchi AU - Kengo Azushima AU - Toshimasa Ohnishi AU - Kouichi Tamura PY - 2026 JO - American Journal of Hypertension DO - 10.1093/ajh/hpag035 UR - https://doi.org/10.1093/ajh/hpag035 ER -
APA
Hanaoka, M., Wakui, H., Kanai, D., Kinguchi, S., Azushima, K., Ohnishi, T., & Tamura, K. (2026). Tolvaptan improves the diurnal blood pressure profile in patients with hypertension and autosomal-dominant polycystic kidney disease. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpag035
Source records
- crossref · retrieved 2026-09-27T07:30:17.100Z